Letter to Editor for Prognostic Value of Systemic Immune-Inflammatory Index in Hospitalized Adolescent COVID-19 Patients
Öz
The study by Çağlar et al., published in your General Medicine Journal (Volume 35/Issue 1, February, pp. 123-128), explores the prognostic role of the Systemic Immune-Inflammation Index (SII) in adolescent COVID-19 patients and its effectiveness in predicting intensive care unit (ICU) admission risk compared to other biomarkers. While the study provides valuable insights into the clinical significance of SII in adolescents, it also has methodological and interpretative limitations. The research highlights SII's potential as a simple, cost-effective biomarker for predicting ICU admission risk (AUC: 0.768, p <0.001), with its calculation based on neutrophil, lymphocyte, and platelet counts aligning well with routine clinical practices. However, the small sample size of ICU-admitted patients (n=14) and the retrospective design limit the generalizability of the findings. Factors such as obesity, time of admission, and SARS-CoV-2 variants were not analyzed, which could influence prognosis. Future multicenter, prospective studies with larger sample sizes and longitudinal data are needed to validate these results and explore SII's dynamic changes during treatment. Despite these limitations, the study makes a significant contribution by demonstrating SII's prognostic value, not only in COVID-19 but also in other conditions like acute cholecystitis and testicular torsion, suggesting its broader clinical utility for early risk stratification and resource optimization in adolescent patients.
Anahtar Kelimeler
Adolescent, COVID-19, Prognoses, systemic immune-inflammatory index
Destekleyen Kurum
The article was not supported by any institution.
Etik Beyan
No ethical declaration approval is required
Kaynakça
- 1. Sperotto F, Friedman KG, Son MBF, VanderPluym CJ, Newburger JW, Dionne A. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021;180(2):307-22.
- 2. Karimi A, Shobeiri P, Kulasinghe A, Rezaei N. Novel systemic inflammation markers to predict COVID-19 prognosis. Front Immunol. 2021;12:741061.
- 3. Fois AG, Paliogiannis P, Scano V, Cau S, Babudieri S, Perra R, et al. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. Molecules. 2020;25(23):5725.
- 4. Halmaciu I, Arbănași EM, Kaller R, Mureșan AV, Arbănași EM, Suciu BA, et al. Chest CT Severity Score and Systemic Inflammatory Biomarkers as Predictors of the Need for Invasive Mechanical Ventilation and of COVID-19 Patients’ Mortality. Diagnostics (Basel). 2022;12(9):2089.
- 5. Yuan H, Tian J, Wen L. Meta-analysis of the systemic immune-inflammatory index and in-hospital mortality of COVID-19 patients. Heliyon. 2023 ;10(1):e23441.
- 6. Xia W, Tan Y, Hu S, Li C, Jiang T. Predictive Value of Systemic Immune-Inflammation Index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19. Clin Appl Thromb Hemost. 2022;28:10760296221111391.
- 7. Fu J, Kong J, Wang W, Wu M, Yao L, Wang Z, et al. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thromb Res. 2020;192:3-8.
- 8. Zhao Y, Yu C, Ni W, Shen H, Qiu M, Zhao Y, et al. Peripheral blood inflammatory markers in predicting prognosis in patients with COVID-19. J Clin Lab Anal. 2021;35(1):e23657.
- 9. Hoang A, Chorath K, Moreira M, Evans M, Burmeister-Morton F, Burmeister F, et al. COVID-19 in 7780 pediatric patients: a systematic review. EClinicalMedicine. 2020;24:100433.
- 10. Morand A, Fabre A, Minodier P, Boutin A, Vanel N, Bosdure E, et al. COVID-19 virus and children: What do we know? Arch Pediatr. 2020;27(3):117-8.